Etiology of neutropenia in HIV-infected patients

被引:11
作者
Jaresko, GS [1 ]
机构
[1] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA
关键词
anti-infective agents; antiretroviral agents; antivirals; cidofovir; foscarnet; ganciclovir; HIV infections; neutropenia; sulfamethoxazole; sulfonamides; toxicity; trimethoprim; zidovudine;
D O I
10.1093/ajhp/56.suppl_5.S5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The causes of neutropenia in HIV-infected patients are described, as is the association of absolute neutrophil count (ANC) and the risk of bacterial infections. In patients with HIV infection, neutropenia can result from the disease or related malignancies, drug therapies, or opportunistic infections. HIV can cause neutropenia by directly or indirectly impairing hematopoiesis. Similarly, microorganisms that cause opportunistic infections, such as cytomegalovirus and Mycobacterium avium complex, can infiltrate the bone marrow and cause myelosuppression. Hematologic toxicities of drug therapy targeted against HIV and opportunistic infections, such as zidovudine, cidofovir, foscarnet, ganciclovir, and trimethoprim/sulfamethoxazole, can further reduce blood cell formation. Several retrospective studies are reviewed that examined the relationship between ANC and the development of bacterial infections in patients infected with HIV. Since neutropenia appears to be associated with increased risk of bacterial infections in HIV-infected patients, approaches to shorten or prevent neutropenia in these patients will likely provide substantial clinical benefit.
引用
收藏
页码:S5 / S8
页数:4
相关论文
共 20 条
[1]   A COMPARATIVE TRIAL OF DIDANOSINE OR ZALCITABINE AFTER TREATMENT WITH ZIDOVUDINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
ABRAMS, DI ;
GOLDMAN, AI ;
LAUNER, C ;
KORVICK, JA ;
NEATON, JD ;
CRANE, LR ;
GRODESKY, M ;
WAKEFIELD, S ;
MUTH, K ;
KORNEGAY, S ;
COHN, DL ;
HARRIS, A ;
LUSKINHAWK, R ;
MARKOWITZ, N ;
SAMPSON, JH ;
THOMPSON, M ;
DEYTON, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (10) :657-662
[2]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[3]   ORAL GANCICLOVIR AS MAINTENANCE TREATMENT FOR CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS [J].
DREW, WL ;
IVES, D ;
LALEZARI, JP ;
CRUMPACKER, C ;
FOLLANSBEE, SE ;
SPECTOR, SA ;
BENSON, CA ;
FRIEDBERG, DN ;
HUBBARD, L ;
STEMPIEN, MJ ;
SHADMAN, A ;
BUHLES, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (10) :615-620
[4]   Clinical guidelines and pharmacist intervention program for HIV-infected patients requiring granulocyte colony-stimulating factor therapy [J].
Engles-Horton, LL ;
Skowronski, C ;
Mostashari, F ;
Altice, FL .
PHARMACOTHERAPY, 1999, 19 (03) :356-362
[5]   TREATMENT WITH LAMIVUDINE, ZIDOVUDINE, OR BOTH IN HIV-POSITIVE PATIENTS WITH 200 TO 500 CD4+ CELLS PER CUBIC MILLIMETER [J].
ERON, JJ ;
BENOIT, SL ;
JEMSEK, J ;
MACARTHUR, RD ;
SANTANA, J ;
QUINN, JB ;
KURITZKES, DR ;
FALLON, MA ;
RUBIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1662-1669
[6]   A RANDOMIZED CONTROLLED TRIAL OF A REDUCED DAILY DOSE OF ZIDOVUDINE IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
FISCHL, MA ;
PARKER, CB ;
PETTINELLI, C ;
WULFSOHN, M ;
HIRSCH, MS ;
COLLIER, AC ;
ANTONISKIS, D ;
HO, M ;
RICHMAN, DD ;
FUCHS, E ;
MERIGAN, TC ;
REICHMAN, RC ;
GOLD, J ;
STEIGBIGEL, N ;
LEOUNG, GS ;
RASHEED, S ;
TSIATIS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1009-1014
[7]  
FRANKLIN LR, 1996, AIDS READER, V6, P185
[8]   MECHANISMS OF CYTOPENIA IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
HARBOL, AW ;
LIESVELD, JL ;
SIMPSONHAIDARIS, PJ ;
ABBOUD, CN .
BLOOD REVIEWS, 1994, 8 (04) :241-251
[9]   CURRENT CONCEPTS - MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
HORSBURGH, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) :1332-1338
[10]  
JACOBSON MA, 1996, 11 INT C AIDS VANC B